Sientra Inc SIENQ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SIENQ is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.06
- Day Range
- $0.04–0.07
- 52-Week Range
- $0.04–4.94
- Bid/Ask
- $0.05 / $0.15
- Market Cap
- $597,885.60
- Volume/Avg
- 126,588 / 2.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.01
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Sientra Inc is a part of the healthcare sector in the United States. Its business involves the provision of silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. Its operating segments are Breast Products and miraDry. The Breast Products segment focuses on sales of breast implants, tissue expanders and scar management products under the brands OPUS, AlloX2, Dermaspan, Softspan, and BIOCORNEUM. The miraDry segment focuses on sales of the miraDry System and bioTips. Geographically, the firm generates a majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 304
- Website
- https://www.sientra.com
Valuation
|
Metric
|
SIENQ
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.01 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
SIENQ
|
|---|---|
Quick Ratio | 0.29 |
Current Ratio | 0.57 |
Interest Coverage | −5.12 |
Quick Ratio
SIENQ
Profitability
|
Metric
|
SIENQ
|
|---|---|
Return on Assets (Normalized) | −35.85% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −89.36% |
Return on Assets
SIENQ
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Yytxmgnpx | Tgzfh | $184.3 Bil | |
SYK
| Stryker Corp | Nnpnqzclz | Ygxpm | $125.0 Bil | |
MDT
| Medtronic PLC | Pnvkwpnx | Yhjsyjv | $107.4 Bil | |
BSX
| Boston Scientific Corp | Qwysvfh | Gvyqts | $106.2 Bil | |
EW
| Edwards Lifesciences Corp | Tpddfjkz | Kpgjwl | $50.8 Bil | |
DXCM
| DexCom Inc | Ztvffwmdv | Bdwr | $50.1 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Zysdcmlsp | Qsjql | $24.6 Bil | |
PHG
| Koninklijke Philips NV ADR | Wgykpdjf | Ggsrzyh | $24.5 Bil | |
ALGN
| Align Technology Inc | Kqzpsmvn | Xwkbsj | $21.4 Bil | |
PODD
| Insulet Corp | Bhrlxgph | Jcncvt | $12.1 Bil |